INTRODUCTION
Bile duct stones are extremely common. They have a potential risk of acute cholangitis or pancreatitis, and they are usually treated under endoscopic retrograde cholangiopancreatography (ERCP) guidance. [1] [2] [3] [4] However, treating bile duct stones is sometimes challenging due to patient factor, such as surgically altered anatomy, a periampullary diverticulum, or a sigmoidshaped common bile duct (CBD), and stones factors, such as a large number or size of stones, intrahepatic bile duct stones, or bile duct stenosis. 5 Electrohydraulic lithotripsy (EHL) under ERCP guidance can be an option to treat difficult stones. [6] [7] [8] [9] Recently, a digital single-operator cholangioscope (SPY-DS; SpyGlass DS, Boston Scientific, Marlborough, MA, USA) has become available. The SPY-DS has several benefits: (1) easier insertion into the biliary tract due to the tapered tip; (2) good visualization through a digital field of view of 120°; and (3) newly added injection and suction functions performed via a 2-port adaptor. This system thus allows the performance of EHL even for intrahepatic bile duct stones. 10, 11 However, if the endoscope cannot be advanced into the ampulla of Vater due to surgically altered anatomy, bile duct stone removal is also challenging. Recently, endoscopic ultrasound-guided biliary drainage (EUS-BD) such as EUSguided hepaticogastrostomy (EUS-HGS) has been developed, 12 and antegrade stone removal has been reported using EUS-BD technique. 13, 14 As an advanced and novel technique, peroral transluminal cholangioscopy (PTLC) has been also reported. 15 under PTLC guidance were evaluated.
MATERIALS AND METHODS
In this pilot study, between July 2016 and July 2017, patients who were complicated with difficult bile duct stones were retrospectively enrolled. All patients provided their written, informed consent to participate before the procedure. This study was approved by the Institutional Review Board of Osaka Medical College Hospital.
Technique of EHL under ERCP guidance
Indications for EHL under ERCP guidance were as follows: (1) large or multiple bile duct stones; (2) intrahepatic bile duct stone; (3) confluence stone; and (4) the presence of a bile duct stricture. First, a duodenoscope (JF260V; Olympus Optical, Tokyo, Japan) was advanced to the ampulla of Vater, and an ERCP catheter (MTW Endoskopie, Düsseldorf, Germany) was inserted into the CBD. Next, a 0.025-inch guidewire (VisiGlide; Olympus Medical Systems, Tokyo, Japan) was placed in the biliary tract. After cholangiography, endoscopic sphincterotomy was performed. An electrohydraulic shock wave generator (Lithotron EL27; Walz Elektronik Gmbh, Herrenberg, Germany) was used to generate shock waves of increasing frequency, which were applied as a continuous sequence of discharges during EHL. A 2.4-F EHL probe was used, and EHL was performed under SPY-DS guidance. To detect bile duct stones more easily, the SPY-DS was used with the mother-baby method, as previously reported. 10 With the combination of operators, bile duct stones can be easily targeted. After fragmentation, bile duct stone removal was performed using standard techniques, such as a basket or balloon catheter. Fig. 1 shows a confluence stone, which was difficult to treat by standard technique. Cholangiography showed a defect lesion, which suggested a bile duct stone with a diameter of 25 mm. First, the SPY-DS was inserted into the biliary tract, and the stone could be observed. Then, EHL was performed under SPY-DS guidance, and stone fragmentation could be obtained. Finally, stone removal was performed using a basket and a balloon catheter, and complete stone clearance was successfully obtained.
Technique of EHL under PTLC guidance
Indications for EHL under PTLC guidance were as follows: (1) ERCP could not be performed due to an inaccessible papilla because of surgically altered anatomy or duodenal obstruction; or (2) a large stone that could not be removed by standard techniques such as a balloon or a basket catheter. In this technique, several steps were needed. First, a fistula had to be created between the biliary tract and stomach. Second, EHL was performed through this fistula. To perform PTLC, EUS-HGS should be performed first. The echoendoscope (GF-UCT260; Olympus Optical) was inserted into the stomach, and the intrahepatic bile duct was detected. Then, the intrahepatic bile duct was punctured using a 19-gauge fine needle aspiration (Sono Tip Pro Control 19G; Medi-Globe GmbH, Achenmühle, Germany; Medico's Hirata, Osaka, Japan) needle using color Doppler to avoid puncturing any vessels. After the bile juice was aspirated, the contrast medium was injected ( Fig. 2A) . After obtaining the image of the biliary tract, the bile duct and stomach wall were dilated using a balloon catheter (REN biliary dilation catheter; Kaneka, Osaka, Japan) or an ERCP catheter (MTW Endoskopie) ( stent (10 mm×100 mm, End-bare type, Niti-S Biliary Cover Stent; TaeWoong Medical, Seoul, Korea; Century Medical, Tokyo, Japan) (Fig. 2C) . Although a 10 cm-long EUS-HGS stent is useful to prevent stent migration, as previously reported, 16, 17 this stent has a limitation in that it is difficult to insert any devices through the stent. Therefore, if devices could not be inserted through the stent, the stent was trimmed, or the mesh of the stent was ruptured, as previously described. 18, 19 After the ERCP catheter was inserted into the EUS-HGS stent, the 0.025-inch guidewire (VisiGlide; Olympus Medical Systems) was advanced into the intestine across the ampulla of Vater, and the contrast medium was injected. If the CBD stone was small, antegrade stone extraction could be performed using a balloon catheter. However, if the CBD stones was large ( Fig. 2A) , antegrade stone extraction could not be performed using only a balloon catheter. Therefore, stone fragmentation was needed. The SPY-DS was antegradely inserted into the CBD, and the stone was visualized ( Fig. 2B and C) . EHL was then performed (Fig. 3A) . After stone fragmentation, the ampulla of Vater was also dilated using a balloon catheter (Fig. 3B) . Lastly, antegrade stone extraction was performed. If the stones were extremely small after EHL, stone extraction was performed through the EUS-HGS stent. During this procedure, to fit the axis, the guidewire was advanced into third part of the duodenum (Fig. 3C) . After stone removal, the metal stent was exchanged to a plastic stent (Type IT, 7 F, 12 cm; Gadelius Medical Co. Ltd., Tokyo, Japan) to maintain the fistula. 20 
Definitions
Stone size was measured by computed tomography or abdominal ultrasound. The number of bile duct stones was also counted on cholangiography. Procedure time was measured from SPY-DS insertion to removal of the duodenoscope with both ERCP and PTLC guidance. Technical success was defined as successful fragmentation using EHL under ERCP or PTLC guidance with a SPY-DS. Descriptive statistics are shown as means±standard deviations or medians and range, as appropriate. Finally, adverse events were graded according to the American Society for Gastrointestinal Endoscopy lexicon's severity grading system. 21 Table 1 shows the patients' characteristics. A total of 42 consecutive patients (27 male, 15 female) with a mean age of 77.1 years underwent EHL using the SPY-DS; 34 patients underwent EHL under ERCP guidance, and the other eight patients underwent EHL under PTLC guidance. Indications for EHL under ERCP guidance were as follows: large, multiple stones (n=18), confluence stone (n=8), intrahepatic bile duct stones (n=6), presence of bile duct stone upstream of a biliary stricture (n=1), and basket impaction (n=1). On the other hand, indications for EHL under PTLC guidance were as follows: surgically altered anatomy (n=7), and malignant duodenal obstruction (n=1).
RESULTS
The maximum median stone size was 27 mm (range, 12 to 37 mm), and the number of stones was as follows: 1 (n=18), 2 (n=6), 3 (n=6), 4 (n=2), >4 (n=2). The median procedure time was 31 minutes (range, 19 to 66 minutes). Technical success was achieved in all patients. The median number of EHL sessions was 1 (range, 1 to 2), and that of ERCP sessions was also 1 (range, 1 to 3). The rate of complete stone clearance was 98% (41/42). One patient who failed complete bile duct stone clearance had a biliary stricture, and multiple stones were seen upstream of this stricture (Fig. 4A) . To access the bile duct stone, fully covered metal stent placement was performed (Fig. 4B) , and then the SPY-DS was inserted. Since a large bile duct stone was seen, EHL was also performed (Fig. 4C-E) . Although many bile duct stones could be removed, complete stone clearance could not be achieved (Fig. 4F ). This patient underwent surgical treatment. Finally, adverse events such as cholangitis and acute pancreatitis were seen in 14% (6/42), which could be treated conservatively.
DISCUSSION
Approximately 10% to 15% of bile duct stones cannot be treated using standard stone removal techniques such as a basket or a balloon catheter. For such difficult stones, EHL has a clinical impact in obtaining stone fragmentation. However, EHL may also be difficult for challenging cases, such as intrahepatic bile duct stones, using a conventional cholangioscope because of limited operability due to two-way deflection and easy breakage. To overcome this problem, the SPY-DS, which has good operability with four-way deflection, and is not as fragile, has become available. However, there have not been enough reports of clinical evaluations of EHL using this scope only for the treatment of bile duct stones. Tanaka et al. 10 reported a singlecenter, retrospective experience with a SPY-DS for diagnostic and therapeutic procedures. In that report, stone fragmentation was successfully performed by laser or EHL with the SPY-DS in 26 patients. Navaneethan et al. 22 reported their experience with the SPY-DS in a multi-center, observational study of 105 patients. Among them, 31 patients with difficult bile duct stones underwent stone therapy by laser lithotripsy. Complete duct clearance in 1 session was achieved in 27 patients (87.1%). As study including only bile duct stone treatment, Wong et al. 23 reported laser lithotripsy with the SPY-DS under ERCP guidance. In their study, 17 patients with difficult stones were prospectively enrolled. The overall stone clearance rate was 94% (16/17) , and the rate of adverse events was 12% (2/17). This result was similar to present study, although there were differences, such as EHL and laser lithotripsy. However, the indication for EHL with the SPY-DS for intrahepatic bile duct stones may be lim- ited for relatively proximal sites. Therefore, peripheral bile duct stones may not be appropriate for this approach, and this is a limitation of this method. Although the present study included a larger number of patients than these previous reports, the critical limitation of the present study is that it was retrospective. Therefore, the present results need to be confirmed by a prospective, multicenter study with a large number of patients. In addition, the treatment of bile duct stones in patients with surgically altered anatomy is sometimes challenging. Percutaneous transhepatic drainage or a surgical approach has been used to treat such bile duct stones. Recently, single-balloon or double-balloon enteroscopy-assisted ERCP has emerged. However, although bile duct stones in patients with surgically altered anatomy may be treated using this technique, the technical success rate is less than 90%, 14 even at high-volume centers or when performed by skilled endoscopists. In the remaining 10%, an alternative method is needed. Recently, EUS-BD has been developed as an alternative method of biliary drainage under ERCP guidance. 12 More recently, antegrade stone removal under EUS-guided biliary access has emerged. This technique has several advantages: (1) short procedure time compared with balloon enteroscopy; (2) ease of reintervention if the tract is maintained using a stent or after completion of a fistula between the bile duct and the gastrointestinal tract; and (3) cosmetic issues. 13 Iwashita et al. 14 reported the use of EUS-guided antegrade (EUS-AS) approach for bile duct stones in patients with surgically altered anatomy in a multicenter, retrospective, cohort study. In their study of 29 patients, 23 were successfully treated by EUS-AS. The median maximum size of the bile duct stones was 10 mm. Adverse adverse events were as follows: mild abdominal pain (n=2); bile peritonitis (n=1); cholecystitis (n=1); and elevation of serum Creactive protein (n=1). EUS-AS was performed using a balloon catheter after endoscopic papillary balloon dilation in this study. However, if the size of stone is large, it might be difficult to remove the stone using only this technique. Itoi et al. 13 reported the successful treatment of a large bile duct stone under EUS-AS guidance. They inserted an over-the-wire type mechanical lithotripsy device into the CBD through a fistula between the intrahepatic bile duct and the jejunum. Although this technique was creative and impressive, there were several concerns. First, this technique cannot be performed for larger bile duct stones. Second, during performance of the stone fragmentation, the risk of bile juice leakage across the fistula may be increased. On the 
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other hand, the present technique has several advantages. First, because of covered metal stent placement, the risk of bile leak during and after EUS-AS may be lower than with the previous technique. Second, stone removal can be performed even if the size of the bile duct stone is large. To the best of our knowledge, this is also the first report of the performance of EHL under antegrade EUS guidance.
In conclusion, EHL using a SPY-DS was technically feasible, not only with ERCP guidance, but also with PTLC guidance. A prospective, multicenter, clinical study of EHL using a SPY-DS is needed.
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